Resolutions of the Extraordinary General Meeting of Biotie Therapies
Corp.
(Thomson Reuters ONE) - BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 29 OCTOBER 2009 at11.00 a.m.Resolutions of the Extraordinary General Meeting of Biotie TherapiesCorp.The Extraordinary General Meeting of Biotie Therapies Corp. was heldon 29 October 2009. The Meeting resolved to approve all proposals.The Board of DirectorsThe number of the members of the Board of Directors was resolved tobe eight and Dr Peter Fellner was elected as a new member of theBoard of Directors.Amendment to the Articles of AssociationThe Extraordinary General Meeting resolved to amend, due to theamendment to the Finnish Companies Act, the method and minimum periodfor publishing the summons to the general meetings in the Article 10of the company's Articles of Association. After the amendment theArticle 10 reads as follows:"10 § Summons to the meetingsThe shareholders of the company are summoned to the shareholders'meeting by publishing the summons on the company's website. Thesummons shall be published not earlier than two (2) months before thelast registration date mentioned in the summons and not later thanthree (3) weeks prior to the date of the meeting. In addition, theBoard of Directors shall publish a summary notice of theshareholders' meeting in one or more national daily newspaper, or bysending the notice of the shareholders' meeting as a registeredletter or other verifiable way to the shareholders' address, which isregistered in the share register."Authorisation of the Board of Directors to decide on an issuance ofshares as well as the issuance of options and other special rightsentitling to sharesThe Extraordinary General Meeting authorised the Board of Directorsto resolve on one or more issues which contains the right to issuenew shares or dispose of the shares in the possession of the companyand to issue options or other specific rights to the shares pursuantto chapter 10 of the Companies Act. The authorisation consists of upto 72,000,000 shares in the aggregate.The authorisation does not exclude the Board of Directors' right todecide on a directed issue. The authorisation may be used formaterial arrangements from the company's point of view, such asfinancing or implementing business arrangements or investments or forother such purposes determined by the Board of Directors in whichcase a weighty financial reason for issuing shares, options or otherspecific rights and possibly directing a share issue exists. Theauthorisation cannot, however, be used to create new share-basedincentive schemes.The Board of Directors was authorised to resolve on all other termsand conditions of a share issue, options and other specific shareentitlements as referred to in chapter 10 of the Companies Act,including the payment period, determination grounds for thesubscription price and subscription price or allocation of shares,option rights or specific rights free of charge or that thesubscription price may be paid besides in cash also by other assetseither partially or entirely.The authorisation is effective until 30 June 2010 and it supersedesearlier authorisations.The minutes of the meeting will be available on the company's websiteas from 12 November 2009.Turku, 29 October 2009Biotie Therapies Corp.Timo VeromaaPresident and CEOFor further information, please contact:Timo Veromaa, President and CEO, Biotie Therapies Corp.tel. +358 2 274 8901, e-mail: timo.veromaa(at)biotie.comwww.biotie.comDISTRIBUTIONNASDAQ OMX Helsinki LtdMain MediaThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 29.10.2009 - 10:00 Uhr
Sprache: Deutsch
News-ID 7606
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 274 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Resolutions of the Extraordinary General Meeting of Biotie Therapies
Corp."
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
